Search

Pharmagest Interactive

Uždarymo kaina

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.8M

17M

Pardavimai

7.2M

116M

P/E

Sektoriaus vid.

16.213

Dividendų pajamingumas

3.08

Pelno marža

14.879

Darbuotojai

1,400

EBITDA

178M

116M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.08%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-24M

583M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Pharmagest Interactive Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-04 23:10; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

2025-11-04 23:51; UTC

Uždarbis
Pagrindinės rinkos jėgos

Arista Networks Expects Slowing Sales Growth, Worrying Investors -- Update

2025-11-04 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

2025-11-04 23:42; UTC

Uždarbis

Naver's Third-Quarter Earnings Rose on AI Push

2025-11-04 23:37; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2025-11-04 23:30; UTC

Uždarbis

Itau Unibanco 3Q Net BRL33.7B >ITUB

2025-11-04 23:25; UTC

Uždarbis

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

2025-11-04 23:25; UTC

Uždarbis

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

2025-11-04 23:24; UTC

Uždarbis

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

2025-11-04 23:23; UTC

Uždarbis

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

2025-11-04 23:06; UTC

Uždarbis

Review & Preview: Tech Check -- Barrons.com

2025-11-04 22:52; UTC

Uždarbis

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

2025-11-04 22:33; UTC

Uždarbis

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

2025-11-04 22:29; UTC

Uždarbis

Ashland 4Q Adj EPS $1.08 >ASH

2025-11-04 22:29; UTC

Uždarbis

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

2025-11-04 22:28; UTC

Uždarbis

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q Cont Ops EPS 73c >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q EPS 71c >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q Sales $478M >ASH

2025-11-04 22:23; UTC

Uždarbis

Ovintiv 3Q EPS 57c >OVV

2025-11-04 22:19; UTC

Rinkos pokalbiai

Canada Budget: Snap Election Talk Might Cool -- Market Talk

2025-11-04 22:16; UTC

Uždarbis

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

2025-11-04 22:14; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

2025-11-04 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

2025-11-04 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Consortium: Able to Finance a Deal With Available Liquidity

2025-11-04 22:12; UTC

Įsigijimai, susijungimai, perėmimai

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

2025-11-04 22:11; UTC

Uždarbis

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

2025-11-04 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

2025-11-04 22:10; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

Pharmagest Interactive Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat